Rockville, MD, April 22, 2024 – U.S. Pharmacopeia (USP) is honored to announce its selection as a member of the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), an organization that brings together biopharmaceutical industry partners across the manufacturing supply chain to support the Biomedical Advanced Research and Development Authority (BARDA).
The BioMaP-Consortium serves a critical role in ensuring that the United States can respond rapidly to public health emergencies by convening public and private industry partners to expand capacity and capabilities to produce medical countermeasures, products that help diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
“We are thrilled to join the BioMaP-Consortium,” said Ronald T. Piervincenzi, Ph.D., CEO of USP. “For more than 200 years, USP has worked to assure the quality of medicines and medical products. We’re proud to leverage our expertise to support BARDA in expanding the manufacturing base for medical countermeasures, including therapeutics and vaccines, to tackle the challenges of today and the biosecurity threats of tomorrow.”
As the nation faces shortages of critical medicines and evolving public health threats, USP will work with the BioMaP-Consortium and its members to advance American industrial and biomanufacturing preparedness and resilience through the development and production of medical countermeasures. This includes working with consortium partners to increase visibility into supply chain vulnerabilities to prioritize medicines that could benefit from bolstered supply chain resilience. In addition, USP will help to accelerate biomanufacturing innovations through analytical method development and process control strategies, particularly for advanced manufacturing technologies, to help assure the quality of medical countermeasures.
About USP
USP is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, dietary supplements and food ingredients. This includes actively collaborating with academic research centers, industry, and regulators to help with the adoption and implementation of advanced manufacturing technologies. Through our resources, standards, advocacy and education, USP helps increase the availability of quality medicines, supplements and foods for billions of people worldwide. For more information, visit: www.usp.org.
USP Media Contact:
Nazila Fathi
This email address is being protected from spambots. You need JavaScript enabled to view it.
(301) 816-8547